Active Ingredient History
Etanercept, sold under the brand name Enbrel among others, is a biologic medical product that is used to treat autoimmune diseases by interfering with tumor necrosis factor (TNF), a soluble inflammatory cytokine, by acting as a TNF inhibitor. It has US Food and Drug Administration (FDA) approval to treat rheumatoid arthritis, juvenile idiopathic arthritis and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. Tumor necrosis factor alpha (TNFα) is the "master regulator" of the inflammatory (immune) response in many organ systems. Autoimmune diseases are caused by an overactive immune response. Etanercept has the potential to treat these diseases by inhibiting TNF-alpha. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acquired Hyperostosis Syndrome (Phase 2/Phase 3)
Acute Lung Injury (Phase 2)
Adenocarcinoma (Phase 1/Phase 2)
Alzheimer Disease (Phase 2)
Ankylosis (Phase 2/Phase 3)
Anorexia (Phase 3)
Arthritis (Phase 4)
Arthropathy, Neurogenic (Phase 4)
Asthma (Phase 2)
Autoimmune Diseases (Phase 1/Phase 2)
Axial Spondyloarthritis (Phase 4)
Bone Diseases (Phase 2/Phase 3)
Bone Diseases, Metabolic (Phase 1)
Bone Neoplasms (Phase 2/Phase 3)
Bronchiolitis Obliterans (Phase 2)
Cachexia (Phase 3)
Chronic Urticaria (Phase 2/Phase 3)
Dermatomyositis (Phase 2/Phase 3)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 3)
Drug Combinations (Phase 4)
Fatigue Syndrome, Chronic (Phase 2)
Fibrosis (Phase 3)
Gout (Phase 4)
Graft vs Host Disease (Phase 3)
Granulomatosis with Polyangiitis (Phase 2/Phase 3)
Gulf War (Phase 1)
Healthy Volunteers (Phase 2)
Hidradenitis Suppurativa (Phase 2)
Histiocytosis, Langerhans-Cell (Phase 2)
HIV Infections (Phase 1)
Hodgkin Disease (Phase 2)
Hypertension (Phase 4)
Hypoglycemia (Phase 1/Phase 2)
Immune System Diseases (Phase 4)
Immunoglobulin Light-chain Amyloidosis (Phase 2)
Inflammation (Phase 4)
Kidney Failure, Chronic (Phase 2)
Kidney Transplantation (Phase 2)
Knee Injuries (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Lichen Planus (Phase 2)
Lung Diseases (Phase 2)
Lung Neoplasms (Phase 2/Phase 3)
Lung Transplantation (Early Phase 1)
Lupus Erythematosus, Cutaneous (Phase 2)
Lupus Erythematosus, Discoid (Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Lupus Nephritis (Phase 2)
Lymphoma (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Melanoma (Phase 4)
Methotrexate (Phase 4)
Mucocutaneous Lymph Node Syndrome (Phase 2)
Musculoskeletal Diseases (Phase 2/Phase 3)
Myelodysplastic Syndromes (Phase 2)
Myocardial Infarction (Phase 4)
Myositis, Inclusion Body (Early Phase 1)
Neoplasm Metastasis (Phase 2/Phase 3)
Neoplasms (Phase 3)
Neuroblastoma (Phase 2)
Obesity (Phase 1)
Occupational Diseases (Phase 1)
Osteoporosis (Phase 1)
Pancreatic Neoplasms (Phase 1/Phase 2)
Pemphigus (Phase 2)
Persian Gulf Syndrome (Phase 1)
Pneumonia (Phase 3)
Polymyalgia Rheumatica (Phase 3)
Postmenopause (Phase 1)
Prostatic Neoplasms (Phase 2/Phase 3)
Psoriasis ()
Pulmonary Disease, Chronic Obstructive (Phase 2/Phase 3)
Pulmonary Fibrosis (Phase 2)
Radiculopathy (Phase 2/Phase 3)
Recurrence (Phase 4)
Respiratory Distress Syndrome (Phase 2)
Rhabdomyosarcoma (Phase 2)
Rheumatic Diseases (Phase 1)
Rheumatic Fever (Phase 4)
Rheumatology (Phase 4)
Sciatica (Phase 1/Phase 2)
Sjogren's Syndrome (Phase 2)
Spinal Diseases (Phase 2/Phase 3)
Spondylarthritis (Phase 2/Phase 3)
Spondylarthropathies (Phase 4)
Spondylitis (Phase 2/Phase 3)
Stevens-Johnson Syndrome (Phase 3)
Stomatitis (Phase 2)
Subarachnoid Hemorrhage (Phase 1)
Substance Withdrawal Syndrome (Phase 3)
Temporomandibular Joint Disorders (Phase 2)
Therapeutic Equivalency (Phase 1)
Tinnitus (Phase 2)
Uveitis (Phase 3)
Vasculitis (Phase 2)
Vitiligo (Phase 2)
Wilms Tumor (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
